Role of β1- and β2-adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfusion

Journal of Cardiovascular Pharmacology

Volumn 41, Issue 3, 2003, Pages 396-405

  Frances, Carole ^a   Nazeyrollas, Pierre ^a   Prevost, Alain ^a   Moreau, Françoise ^a   Pisani, Jean ^a   Davani, Siamak ^b   Kantelip, Jean Pierre ^b   Millart, Hervé ^a  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

Author keywords

Adrenoceptor; Atenolol; ICI 118,651; Isoproterenol; Perfused rat heart; Preconditioning

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CREATINE KINASE; ISOPRENALINE; NORADRENALIN; PROPANOL; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BETA ADRENERGIC STIMULATION; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; HEART FAILURE; HEART INFARCTION PREVENTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REPERFUSION INJURY;

ADRENERGIC AGONISTS; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL REPERFUSION INJURY; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2;

EID: 0037371097     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200303000-00008     Document Type: Article

References (45)

1. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124-36.
2. Gottlieb RA, Gruol DL, Zhu JY, et al. Preconditioning in rabbit cardiomyocytes: role of pH, vacuolar proton ATPase, and apoptosis. J Clin Invest. 1996;97:2391-8.
3. 1-adrenergic mechanism. Circ Res. 1993;73:656-70.
4. 3 receptors. Cardiovasc Res. 2001;51:701-8.
5. Asimakis GK, Inners-McBride K, Conti VR, et al. Transient β-adrenergic stimulation can precondition the rat heart against postischaemic contractile dysfunction. Cardiovasc Res. 1994;28:1726-34.
6. Asimakis GK, Conti VR. Preconditioning with dobutamine in the isolated rat heart. Life Sci. 1995;57:177-87.
7. Miyawaki H, Ashraf M. Isoproterenol mimics calcium preconditioning-induced protection against ischemia. Am J Physiol. 1997;272(2 part 2):H927-36.
8. Yabe K, Ishishita H, Tanonaka K, et al. Pharmacologic preconditioning induced by beta-adrenergic stimulation is mediated by activation of protein kinase C. J Cardiovasc Pharmacol. 1998;32:962-8.
9. Obata T, Yamanaka Y. Reserpine attenuates interstitial adenosine-mediated activation of ecto-5′-nucleotidase in rat hearts in vivo. Arch Biochem Biophys. 2000;375:333-9.
10. Lochner A, Grenade S, Tromp E, et al. Ischemic preconditioning and the β-adrenergic signal transduction pathway. Circulation. 1999;100:958-66.
11. Okruhlicova I, Ravingerova T, Pancza D, et al. The role of adenylate cyclase in ischemic preconditioning in the rat heart: a cytochemical study. Gen Physiol Biophys. 1999;18(suppl 1):44-7.
12. Prevost A, Leperre A, Moreau F, et al. Cardiotoxic effects of salmeterol in comparison with salbutamol on the isolated perfused Langendorff-heart of the rat. Arzneimittelforschung. 1997;47:39-43.
13. de Jong JW, de Jonge R, Keijzer E, et al. The role of adenosine in preconditioning. Pharmacol Ther. 2000;87:141-9.
14. Bankwala Z, Hale SL, Kloner RA. β-Adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. Circulation. 1994;90:1023-8.
15. Weselcouch EO, Baird AJ, Sleph PG, et al. Endogenous catecholamines are not necessary for ischaemic preconditioning in the isolated perfused rat heart. Cardiovasc Res. 1995;29:126-32.
16. Schultz JE, Gross GJ. Opioids and cardioprotection. Pharmacol Ther. 2001;89:123-237.
17. Nasa Y, Yabe K, Takeo S. β-Adrenoceptor stimulation-mediated preconditioning-like cardioprotection in perfused rat hearts. J Cardiovasc Pharmacol. 1997;29:436-43.
18. Parikh V, Singh M. Possible role of adrenergic component and cardiac mast cell degranulation in preconditioning-induced cardioprotection. Pharmacol Res. 1999;40:129-37.
19. 2+ as a mediator of ischemic preconditioning. Circ Res. 1997;80:790-9.
20. De Jonge R, Out M, Maas WJ, et al. Preconditioning of rat hearts by adenosine A1 or A3 receptor activation. Eur J Pharmacol. 2002;441:165-72.
21. Strasser RH, Braun-Dullaeus R, Walendzik H, et al. β1-Receptor-independent activation of protein kinase C in acute myocardial ischemia: mechanisms of sensitization of the adenylyl cyclase system. Circ Res. 1992;70:1304-12.
22. Winter CB, Cleveland JC, Butler KL, et al. Facilitative interactions between noradrenergic and purinergic signaling during preconditioning of the rat heart. J Mol Cell Cardiol. 1997;29:163-73.
23. Miyawaki H, Zhou X, Ashraf M. Calcium preconditioning elicits strong protection against ischemic injury via protein kinase C signaling pathway. Circ Res. 1996;79:137-46.
24. Boknik P, Khorchidi S, Bodor GS, et al. Role of protein phosphatases in regulation of cardiac inotropy and relaxation. Am J Physiol Heart Circ Physiol. 2001;280:H786-94.
25. 2+ mobilization by extracellular ATP in rat cardiac myocytes: regulation by protein kinase C and A. Am J Physiol. 1992;263(5 part 1):C933-40.
26. 2+ channels. Nature. 1998;335:249-51.
27. 2-adrenergic receptor, study model for agonist-induced desensitization. Med Sci. 1995;11:819-27.
28. 2-adrenergic receptor. J Recept Signal Transduct Res. 2000;20:75-85.
29. Houslay MD. "Crosstalk": a pivotal role for protein kinase C in modulating relationships between signal transduction pathways. Eur J Biochem. 1991;195:9-27.
30. 1 receptor anti-adrenergic effect in rat cardiac myocytes. Am J Physiol Heart Circ Physiol. 2000;278:H1-7.
31. 2-selective adrenoceptor antagonist (ICI 118,551). J Cardiovasc Pharmacol. 1983;5:430-7.
32. Matthews JC, Baker JK. Effects of propranolol and a number of its analogues on sodium channels. Biochem Pharmacol. 1982;31:1681-5.
33. 1- and β-adrenoceptor subtypes in the rat atrioventricular node by quantitative autoradiography. Circ Res. 1988;62:173-7.
34. 2-Adrenoceptors and ventricular fibrillation. Pharmacol Ther. 2000;88:1-14.
35. Vegh A, Papp JG, Kasal K, et al. Cardiac pacing in anaesthetized dogs preconditions the heart against arrhythmias when ischemia is induced 24h later. J Physiol. 1994;480. Abstract.
36. Hearse DJ, Ferrari R, Sutherland FJ. Cardioprotection: intermittent ventricular fibrillation and rapid pacing can induce preconditioning in the blood-perfused rat heart. J Mol Cell Cardiol. 1999;31:1961-73.
37. 2+ dynamics, contractility, or phospholamban phosphorylation. J Biol Chem. 1994;269:19151-6.
38. i proteins and its physiological relevance in murine cardiac myocytes. Circ Res. 1999;84:43-52.
39. 2 in the endothelial protective effect of ischaemic preconditioning in isolated rat heart. Cardiovasc Res. 2000;45:418-27.
40. Lau YH, Robinson RB, Rosen MR, et al. Subclassification of β-adrenergic receptors in cultured rat cardiac myoblasts and fibroblasts. Circ Res. 1980;47:41-8.
41. Anthonio RL, Brodde OE, Van Veldhuisen DJ, et al. β-Adrenoceptor density in chronic infarcted myocardium: a subtype specific decrease of β-adrenoceptor density. Int J Cardiol. 2000;72:137-41.
42. Schrör K, Zimmermann KC, Tannhauser R. Augmented myocardial ischaemia by nicotine: mechanisms and their possible significance. Br J Pharmacol. 1998;125:79-86.
43. Parikh V, Singh M. Cardiac mast cell stabilization and cardioprotective effect of ischemic preconditioning in isolated rat heart. J Cardiovasc Pharmacol. 1998;31:779-85.
44. 3H]-dihydroalprenolol binding and inhibition of histamine release. Naunyn Schmiedebergs Arch Pharmacol. 1982;321:171-6.
45. Marquardt DL, Wasserman SI. Characterization of the rat mast cell β-adrenergic receptor in resting and stimulated cells by radioligand binding. J Immunol. 1982;129:2122-7.